128 related articles for article (PubMed ID: 11243702)
1. Cytokine dependency of human B cell cycle progression elicited by ligands which coengage BCR and the CD21/CD19/CD81 costimulatory complex.
Mongini PK; Inman JK
Cell Immunol; 2001 Feb; 207(2):127-40. PubMed ID: 11243702
[TBL] [Abstract][Full Text] [Related]
2. Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway.
Mongini PK; Highet PF; Inman JK
J Immunol; 1995 Oct; 155(7):3385-400. PubMed ID: 7561033
[TBL] [Abstract][Full Text] [Related]
3. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
Luxembourg AT; Cooper NR
J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
[TBL] [Abstract][Full Text] [Related]
4. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
Sato S; Miller AS; Howard MC; Tedder TF
J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
[TBL] [Abstract][Full Text] [Related]
5. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
[TBL] [Abstract][Full Text] [Related]
6. Antigen receptor triggered upregulation of CD86 and CD80 in human B cells: augmenting role of the CD21/CD19 co-stimulatory complex and IL-4.
Mongini PK; Tolani S; Fattah RJ; Inman JK
Cell Immunol; 2002; 216(1-2):50-64. PubMed ID: 12381350
[TBL] [Abstract][Full Text] [Related]
7. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
[TBL] [Abstract][Full Text] [Related]
8. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
Rickert RC
Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
[TBL] [Abstract][Full Text] [Related]
9. The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts.
Cherukuri A; Shoham T; Sohn HW; Levy S; Brooks S; Carter R; Pierce SK
J Immunol; 2004 Jan; 172(1):370-80. PubMed ID: 14688345
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4.
Rigley KP; Callard RE
Eur J Immunol; 1991 Mar; 21(3):535-40. PubMed ID: 1707000
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells.
Roberts T; Snow EC
J Immunol; 1999 Apr; 162(8):4377-80. PubMed ID: 10201971
[TBL] [Abstract][Full Text] [Related]
12. Innate immunity and human B cell clonal expansion: effects on the recirculating B2 subpopulation.
Mongini PK; Inman JK; Han H; Kalled SL; Fattah RJ; McCormick S
J Immunol; 2005 Nov; 175(9):6143-54. PubMed ID: 16237111
[TBL] [Abstract][Full Text] [Related]
13. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
Boackle SA; Morris MA; Holers VM; Karp DR
J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
[TBL] [Abstract][Full Text] [Related]
14. Membrane IgM-stimulated human B lymphocytes succumb to activation-related apoptosis at a G1-->S transition: influence of ligand affinity and valency.
Mongini PK; Vilensky MA; Highet PF; Inman JK
Cell Immunol; 1998 Sep; 188(2):137-50. PubMed ID: 9756644
[TBL] [Abstract][Full Text] [Related]
15. The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13.
Bradbury LE; Goldmacher VS; Tedder TF
J Immunol; 1993 Sep; 151(6):2915-27. PubMed ID: 7690791
[TBL] [Abstract][Full Text] [Related]
16. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
[TBL] [Abstract][Full Text] [Related]
17. Membrane IgM-mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation.
Mongini PK; Blessinger CA; Highet PF; Inman JK
J Immunol; 1992 Jun; 148(12):3892-901. PubMed ID: 1376344
[TBL] [Abstract][Full Text] [Related]
18. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
[TBL] [Abstract][Full Text] [Related]
19. The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2).
Mongini PK; Vilensky MA; Highet PF; Inman JK
J Immunol; 1997 Oct; 159(8):3782-91. PubMed ID: 9378965
[TBL] [Abstract][Full Text] [Related]
20. Depletion of Lyn kinase from the BCR complex and inhibition of B cell activation by excess CD21 ligation.
Chakravarty L; Zabel MD; Weis JJ; Weis JH
Int Immunol; 2002 Feb; 14(2):139-46. PubMed ID: 11809733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
